Patient Enrollment Commenced in Pivotal Phase 3 Trial of Cardiamp Cell Therapy for the Treatment of Ischemic Heart Failure
電芯治療用於缺血性心力衰竭的關鍵性3期臨床試驗開始患者招募。
Patient Enrollment Commenced in Pivotal Phase 3 Trial of Cardiamp Cell Therapy for the Treatment of Ischemic Heart Failure
電芯治療用於缺血性心力衰竭的關鍵性3期臨床試驗開始患者招募。
譯文內容由第三人軟體翻譯。